Procyon (PCYN)

Procyon Corp. is a holding company, which engages in the development and marketing of proprietary medical products. Its products include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, and EXTREMIT-EASE Compression Garment. The company was founded on March 19, 1987 and is headquartered in Clearwater, FL.

Company profile

Ticker

PCYN

Exchange

OTC

Website

procyoncorp.com

CEO

Justice Wolfe Anderson

Incorporated

Colorado

Location

Florida

Fiscal year end

Jun 30

Sector

Health Technology > Pharmaceuticals: Major

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Allergan • Abbott Laboratories • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie ...

SEC CIK

0000812306

Corporate docs

Articles of Incorporation & Bylaws

Material Contracts & Credit Agreements

IRS number

368732690

PCYN stock data

1M 1Y 5Y

Calendar

16 May 22

2 Jul 22

30 Jun 23

Financial summary

Financial statements Chart PCYN financial data

Quarter (USD)	Mar 22	Dec 21	Sep 21	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jun 21	Jun 20	Jun 19	Jun 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Procyon earnings reports.

Recent insider trades

PCYN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
31 Mar 22	Foundation Speer	Common Stock	Sell	Dispose S	No	No	0	40,000	0	1,460,000
7 Feb 22	Foundation Speer	Common Stock	Sell	Dispose S	No	No	0	15,000	0	1,500,000
6 Dec 21	Foundation Speer	Common Stock	Sell	Dispose S	No	No	0	25,000	0	1,515,000
30 Jun 21	Justice Wolfe Anderson	Stock Option Common Stock	Grant	Acquire A	No	No	0.373	25,000	9.33K	25,000
30 Jun 21	James Brian Anderson	Stock Option Common Stock	Grant	Acquire A	No	No	0.373	25,000	9.33K	25,000
30 Jun 17	Justice Wolfe Anderson	Stock Option Common Stock	Grant	Acquire A	No	No	0.19	25,000	4.75K	25,000
30 Jun 16	Justice Wolfe Anderson	Stock Option Common Stock	Grant	Acquire A	No	No	0.15	40,000	6K	40,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2021

PCYN institutional ownership history Ownership history

19.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1	1	–
Opened positions	0	1	EXIT
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	0	0
Total shares	1.56M	1.56M	–
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Foundation Speer	1.56M	$0	0.0%

Largest transactions	Shares	Bought/sold	Change
Foundation Speer	1.56M	0	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

Management Discussion

Revenues. Revenues decreased by $1.5 million, or 17%, from $8.8 million for the three months ended March 31, 2021 to $7.3 million for the three months ended March 31, 2022. The decrease was mainly driven by a contract reduction from our largest customer (as first disclosed in the Q3 2020 Form 10-Q), which was effective in Q2 2021. The revenue impact of this contract reduction was $0.7 million. Additionally, revenue was adversely impacted by customer contracts renewals at lower values and churn coupled with the end of life of several legacy products that began during 2020. These declines were offset by new customers added in 2021 and 2022 in our Threat Detection and email security businesses.
During the second quarter of 2020, the Company released two new products, Cyren Inbox Security and Threat InDepth. Since these product launches, the Company has signed numerous new customer contracts representing over $3.3 million in estimated revenue over the lives of the contracts, but due to the timing, duration and ratable nature of the contracts, there was not a material amount of revenue recognized for the three months ended March 31, 2022 or March 31, 2021.
Cost of Revenues. Cost of revenues for the three months ended March 31, 2022 was consistent with cost of revenues for the three months ended March 31, 2021. For the three months ended March 31, 2022, cost of revenues represented 53% of revenue, compared to 43% during the same period in the prior year, and accordingly, gross margins for the period were 47% for the three months ended March 31, 2022 compared to 57% for the same period in the prior year, primarily due to the decline in revenue. Payroll and related expenses decreased by $0.1 million or 1% primarily due to a decline in headcount from 36 employees as of March 31, 2021, compared to 31 as of March 31, 2022. Offsetting some of this decrease was an increase of $0.1 million in share-based compensation related to new equity awards issued in the period ending March 31, 2022. Other costs of revenue expenses increased by $0.1 million or 3% primarily due to an increase in costs associated with maintaining our datacenters.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: acquired, Additionally, alternative, Alternatively, assist, automatically, began, book, case, charge, collateralized, conflict, cyberterrorism, datacenter, discontent, displacement, duration, economy, environment, equivalent, escalation, EU, Europe, eventually, fleeing, float, fractional, furniture, goodwill, hired, humanitarian, impaired, impairment, inflation, interruption, lessor, located, longer, military, minimal, modification, multiple, nearest, par, party, phase, popular, precise, premise, privacy, proceed, promotion, protracted, qualitative, quantitative, range, ratio, region, repaid, Restated, retroactively, ROU, Russia, Russian, salary, social, source, step, strategy, sustained, test, tested, testing, thirty, turn, twenty, Ukraine, unaffiliated, unforeseen, vacation, volatility, wider

Removed: agreed, alleged, amend, antimalware, application, applied, appointed, attributable, Aviv, bad, blackout, breaching, built, Claim, claimed, combat, commitment, comparative, complaint, contended, controlling, corroborated, court, covering, create, cure, cybersecurity, database, Defense, delete, denied, direction, discounted, disease, dismissed, District, enriched, entirety, epidemic, examine, final, fully, Germany, gradually, half, health, hierarchy, highly, Iceland, identification, implemented, implicit, indemnify, index, infringing, initially, injunctive, issuable, judgment, jurisdiction, launch, lawsuit, level, mediation, mediator, method, misappropriated, mitigating, modified, monetary, negatively, negotiating, newest, observable, October, operational, ordering, outbreak, package, partial, partnership, personal, piggyback, platform, policy, post, postpone, predicted, prejudice, Pretrial, Purpose, quoted, reached, readily, receipt, recommendation, recording, refinance, relief, remeasurement, removing, renegotiate, renewal, resale, respiratory, restructure, restructuring, retrospective, scheduled, seek, settlement, Simplifying, situation, SOC, sought, spread, strategic, structure, subsequent, Tel, terminated, Topic, transition, ultimate, unjustly, utilize, utilizing, variable, Warburg

From filing 10-Q 2022 Q1

Financial reports

View all